WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark HemaTrack was filed as Word mark on 03/03/2023 at the World Intellectual Property Organization.
| Trademark form | Word mark |
| File reference | 1724975 |
| Register number | 302022115216 |
| Countries | 
|
| Base trademark |
No. 30 2022 115 216,
January 31, 2023
|
| Application date | March 3, 2023 |
| Expiration date | March 3, 2033 |
Trademark owner
St. Petersburger Str. 2
01069 Dresden
DE
01069 Dresden
DE
Trademark representatives
Königsallee 62
40212 Düsseldorf
DE
goods and services
01
Diagnostic and research products [other than for medical or
veterinary purposes], namely, reagents and buffer solutions,
enzymes, molecular probes, PCR additives, DNA and RNA
polymerases, nucleic acid derivatives, primers for use in
PCR; nucleic acids or their derivatives, dyes and
biotechnology reagents and solvents for sample preparation,
purification, lysis, modification and manipulation of cells;
kits containing the aforementioned goods; molecules applied
as sensors for scientifically relevant processes or
mechanisms
05
Biological preparations sold in a kit, containing reagents
and buffer solutions, enzymes, molecular probes, PCR
additives, DNA and RNA polymerases, nucleic acid
derivatives, primers to amplify and quantify target nucleic
acids [biological preparations for medical purposes];
biological preparations for the treatment, monitoring or
diagnosis of disease; diagnostic preparations for clinical
or medical use; medical preparations for clinical or imaging
applications; molecules applied as sensors for clinical
approaches
42
Laboratory services making use of quantitative sequencing
methods; quantitative determination of one or more target
nucleic acids; quantitative analysis based on sequencing for
scientific research purposes; monitoring or comparison of
target nucleic acids between two or more samples; providing
assays and testing services for residual disease; research
and development of new methods in the field of
biotechnology; providing lab service in the field of
hematology, design and development of computer software and
algorithms; quantitative analysis based on sequencing for
clinical research purposes or clinical trials; research and
development in the pharmaceutical field or for the purposes
of treatment of patients; providing lab service in the field
of cancer, vaccine development, genetic testing or clinical
monitoring of the immune system in its entirety or parts
thereof, design and development of computer software,
algorithms and analysis tools
44
Medical analysis services for diagnostic and treatment
purposes provided by medical laboratories, especially using
quantitative sequencing methods; performing medical analysis
by a medical laboratory regarding the treatment of
individuals, namely quantitative determination of one or
more target nucleic acids; monitoring or comparison of
target nucleic acids between two or more samples from the
same individual [medical laboratory services for the
analysis of samples of a patient]; medical analysis services
for diagnostic and treatment purposes provided by medical
laboratories, namely providing assays and diagnostic or
prognostic testing services for residual disease, and the
analysis, evaluation, and reporting of those test results to
help healthcare professionals determine a patient's clinical
diagnosis, the effectiveness of patient treatments, and to
revise future treatments accordingly
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| July 5, 2023 | 2023/27 Gaz | GB | Rejection |
| March 3, 2023 | 2023/13 Gaz | DE | Registration |
ID: 141724975